Literature DB >> 6109019

[3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain.

S J Peroutka, S H Snyder.   

Abstract

Mianserin, a tetracyclic antidepressant, is a potent serotonin (5-HT) and histamine H1 antagonist in peripheral smooth muscle systems. Mianserin was found to possess high affinity for 5-HT2 and histamine H1 receptor binding sites in brain membranes. By using [3H]mianserin, both 5-HT2 and histamine H1 receptors can be specifically labeled in rat cerebral cortex membranes. Simultaneous incubation of brain membranes with 300 nM triprolidine or 30 nM spiroperidol enables the selective labeling of 5-HT2 or histamine H1 receptors, respectively. In the guinea-pig cerebellum, [3H]mianserin exclusively labels histamine H1 receptors, since 5-HT2 sites are virtually absent in this area.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6109019

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Effects of ketanserin and mianserin on delayed neuronal death induced by cerebral ischemia in Mongolian gerbils.

Authors:  Y Karasawa; H Araki; S Otomo
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Central serotonin receptors: effector systems, physiological roles and regulation.

Authors:  P J Conn; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats.

Authors:  C T Dourish; M L Clark; A Fletcher; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.

Authors:  Jenny L Wiley; Timothy W Lefever; Julie A Marusich; Megan Grabenauer; Katherine N Moore; John W Huffman; Brian F Thomas
Journal:  Neuropharmacology       Date:  2016-07-20       Impact factor: 5.250

5.  The serotonin2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin is no longer effective.

Authors:  B S Neal; S B Sparber
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

7.  The responsiveness of cerebral cortical adrenergic receptors after chronic administration of atypical antidepressant mianserin.

Authors:  I Nalepa; J Vetulani
Journal:  J Psychiatry Neurosci       Date:  1994-03       Impact factor: 6.186

8.  Studies on rat intestinal epithelial cell receptors for serotonin and opiates.

Authors:  T S Gaginella; T J Rimele; M Wietecha
Journal:  J Physiol       Date:  1983-02       Impact factor: 5.182

9.  A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.

Authors:  C T Dourish
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

10.  Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity.

Authors:  T H Hand; G J Marek; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.